Related Experiment Videos
HLA C associations with acute leukaemia
Lancet (London, England)
|November 24, 1984
Summary
Certain HLA antigens, Cw3 and Cw4, are significantly linked to increased acute leukaemia risk. These findings suggest potential genetic markers for leukaemia susceptibility or treatment response in patients undergoing bone marrow transplantation.
Area of Science:
- Immunogenetics
- Oncology
Background:
- Human Leukocyte Antigen (HLA) genes play a crucial role in immune response and disease susceptibility.
- Bone marrow transplantation (BMT) is a vital treatment for various leukaemias, with HLA matching influencing outcomes.
Purpose of the Study:
- To investigate the association between specific HLA antigen frequencies and leukaemia in patients treated with BMT.
- To identify potential HLA markers related to leukaemia susceptibility or treatment response.
Main Methods:
- Retrospective analysis of HLA A, B, C, and DR antigen frequencies.
- Data collected from 1009 leukaemia patients reported to the International Bone Marrow Transplant Registry.
- Statistical analysis to determine significant associations between HLA antigens and leukaemia subtypes.
Main Results:
- Significant associations were found between HLA-Cw3 and HLA-Cw4 antigens and acute leukaemia.
- HLA-Cw3 and Cw4 showed significant links with acute lymphoblastic leukaemia.
- HLA-Cw4 was also significantly associated with acute myelogenous leukaemia.
Conclusions:
- HLA-Cw3 and Cw4 may serve as genetic markers for leukaemia susceptibility.
- These antigens could indicate altered immune responsiveness to potential leukaemia viruses.
- The findings suggest a possible role in regulating chemotherapy response and remission achievement in BMT patients.